Exploiting the defensive sugars of HIV-1 for drug and vaccine design 由 Scanlan, C, Offer, J, Zitzmann, N, Dwek, R

Emerging principles for the therapeutic exploitation of glycosylation. 由 Dalziel, M, Crispin, M, Scanlan, C, Zitzmann, N, Dwek, R

Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens 由 Dunlop, D, Ulrich, A, Dwek, R, Zitzmann, N, Scanlan, C

Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions. 由 Baruah, K, Bowden, T, Krishna, B, Dwek, R, Crispin, M, Scanlan, C

Selective deactivation of serum IgG: A general strategy for the enhancement of monoclonal antibody receptor interactions 由 Baruah, K, Bowden, T, Krishna, B, Dwek, R, Crispin, M, Scanlan, C

Sugar immunogens 由 Dwek, R, Scanlan, C, Dunlop, D, Mansab, F, Tully, S, Wentworth, P, Zitzmann, N

Liposome treatment of viral infections 由 Dwek, R, Nichita-Branza, N, Petrescu, S, Pollock, S, Rudd, P, Scanlan, C, Zitzmann, N

Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12 由 Fulton, Z, Doores, K, Scanlan, C, Wormald, M, Dwek, R, Wilson, I, Davis, B

Antigenic mimicry of the HIV envelope by AIDS-associated pathogens. 由 Dunlop, D, Ulrich, A, Appelmelk, B, Burton, D, Dwek, R, Zitzmann, N, Scanlan, C

Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens 由 Doores, K, Bonomelli, C, Harvey, D, Vasiljevic, S, Dwek, R, Burton, D, Crispin, M, Scanlan, C

P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope 由 Dwek R, Burton D, Smith D, Zitzmann N, Doores K, Mansab F, Dunlop DC, Scanlan C

Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope 由 Dunlop, D, Mansab, F, Doores, K, Zitzmann, N, Smith, D, Burton, D, Dwek, R, Scanlan, C

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. 由 Bonomelli, C, Doores, K, Dunlop, D, Thaney, V, Dwek, R, Burton, D, Crispin, M, Scanlan, C

A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity 由 Doores, K, Fulton, Z, Scanlan, C, Wormald, M, Dwek, R, Wilson, I, Burton, DR, Davis, B

Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies 由 Yu, X, Baruah, K, Harvey, D, Vasiljevic, S, Alonzi, D, Song, B, Higgins, M, Bowden, T, Scanlan, C, Crispin, M

An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling. 由 Goodfellow, J, Baruah, K, Yamamoto, K, Bonomelli, C, Krishna, B, Harvey, D, Crispin, M, Scanlan, C, Davis, B

Redirecting adenoviruses to tumour cells using therapeutic antibodies: generation of a versatile human bispecific adaptor 由 Vasiljevic, S, Beale, E, Bonomelli, C, Easthope, I, Pritchard, L, Seabright, G, Caputo, A, Scanlan, C, Dalziel, M, Crispin, M

Use of the α-mannosidase I inhibitor kifunensine allows the crystallization of apo CTLA-4 homodimer produced in long-term cultures of Chinese hamster ovary cells 由 Yu, C, Crispin, M, Sonnen, A, Harvey, D, Chang, V, Evans, E, Scanlan, C, Stuart, D, Gilbert, R, Davis, S

A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind... 由 Astronomo, R, Lee, H, Scanlan, C, Pantophlet, R, Huang, C, Wilson, I, Blixt, O, Dwek, R, Wong, C, Burton, DR

A novel form of carbohydrate recognition. The broadly neutralizing anti-HIV-1 antibody 2G12 recognizes a cluster of a1-2 mannose residues on the outer face of GP120 由 Rudd, P, Scanlan, C, Pantophlet, R, Wormald, M, Saphire, E, Stanfield, R, Wilson, I, Katinger, H, Dwek, R, Burton, DR